Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
FDA · 5 medicines
AEMPS · 4 medicines
ALIMS · 2 medicines
Anvisa · 1 medicine
EMA · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
4 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Omvoh 200 MG Solucion Inyectable en Pluma Precargada | Spain | 200 mg | solución inyectable en pluma precargada | Marketed | Eli Lilly Nederland B.V. |
| Omvoh 100 MG Solucion Inyectable en Pluma Precargada + Omvoh 200 MG Solucion Inyectable en Pluma Precargada | Spain | 100 mg/ml | solución inyectable en pluma precargada | Marketed | Eli Lilly Nederland B.V. |
| Omvoh 300 MG Concentrado Para Solucion Para Perfusion | Spain | 300 mg | concentrado para solución para perfusión | Marketed | Eli Lilly Nederland B.V. |
| Omvoh 100 MG Solucion Inyectable en Pluma Precargada | Spain | 100 mg | solución inyectable en pluma precargada | Authorised | Eli Lilly Nederland B.V. |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, EMA, FDA, HALMED and Health Canada. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
